{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ02336",
      "entity_text" : "sBT",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false,
    "context" : {
      "CellLine" : [ "cellosaurus:CVCL_3020" ],
      "TissueType" : [ "tissuelist:TS-0934" ],
      "Species" : [ "taxonomy:9606" ]
    }
  },
  "verbose_text" : "Moreover, the systematic application of the REMA score in patients presenting with symptoms related with MC activation in the absence of skin lesions evaluated by the REMA has allowed not only to decrease the number of BM studies carried out in these group of patients, but also to identify an increasing number of patients with ISMs- (and MMAS) showing normal sBT levels (~ 10% of all ISMs- cases in the updated series of the REMA, data not published).",
  "reading_complete" : "2020-08-04T11:13:06Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T11:10:34Z",
  "trigger" : "levels",
  "evidence" : [ "sBT levels" ],
  "pmc_id" : "5502410",
  "score" : 0
}